North America plasma fractionation market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 6.7% in the forecast period of 2021 to 2028 and is expected to reach USD 20,855.60 million by 2028.
Get a sample of the report
Market Analysis and Insights: North America Plasma Fractionation Market
North America plasma fractionation market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 6.7% in the forecast period of 2021 to 2028 and is expected to reach USD 20,855.60 million by 2028. High presence of number of plasma collection centres are helping in growing demand of the plasma fractionation market.
Plasma is a blood component that derives from whole blood by plasmapheresis and is used for various therapeutic and medical applications. Human plasma is s source of numerous different proteins. However, only few of these proteins are useful for producing therapeutic plasma products. The process of separation, extraction and purification of these proteins from the plasma is called fractionation process.
North America Plasma Fractionation Market Scope and Market Size
North America plasma fractionation market is segmented into six notable segments which are based on the product type, application, processing technology, mode, end user and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
· On the basis of product type, the plasma fractionation market is segmented into immunoglobulins, coagulation factor concentrate, albumin, protease inhibitors and other products. In 2021, immunoglobulin has the largest market share owing to the effectiveness in treatment of the auto immune disorders due to the immunomodulatory functions
· On the basis of application, the plasma fractionation market is segmented into neurology, immunology, haematology, critical care, pulmonology, hemato- oncology, rheumatology and others. In 2021, immunology has the largest market share owing to the increase in the usage of plasma fractionated proteins in the treatment of various immunology related diseases.
· On the basis of processing technology, the plasma fractionation market is segmented into Ion- exchange chromatography, affinity chromatography, cryopreservation, ultrafiltration and microfiltration. In 2021, Ion- exchange chromatography has the largest market share owing to the high efficiency in the plasma fractionation process for extracting the plasma proteins
· On the basis of mode, the plasma fractionation market is segmented into modern plasma fraction and traditional plasma fractionation. In 2021, modern plasma fractions have the largest market share owing to the adoption the new and innovative technologies in order to reduce the impurities in the plasma fractionation process.
· On the basis of end user, the plasma fractionation market is segmented into Hospitals & clinics, clinical research laboratories academic institutions and others. In 2021, hospitals & clinics has the largest market share due to increasing incidences of various diseases and emerging treatment techniques using plasma fractionated proteins.
North America Plasma Fractionation Market: Country-Level Analysis
North America plasma fractionation market is analysed and market size information is provided by country, product type, application, processing technology, mode, end user and distribution channel as referenced above.
The countries covered in the North America plasma fractionation market report are U.S., Canada and Mexico.
U.S. is dominating in the North America plasma fractionation market with the highest CAGR as the geriatric population and immune deficiency diseases are rising in this region.
Competitive Landscape and North America Plasma Fractionation Market Share Analysis
North America plasma fractionation market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, India presence, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to the North America plasma fractionation market.
Key Players
Some of the major players operating in the plasma fractionation market are Grifols, S.A., Takeda Pharmaceutical Company Limited, Octapharma AG, CSL Plasma, LFB SA, Green Cross Corp., Baxter, Bio Products Laboratory Ltd., Novasep Holding SAS, Pall Corporation, Bharat Serums and Vaccines Limited (BSV), Kedrion S.p.A, Sanquin, Biotest AG, Merck KGaA, ADMA Biologics, Inc., Boccard, Intas Pharmaceuticals Ltd., Japan Blood Products Organization and CENTURION Ilaç Sanayi ve Ticaret A.S. among others. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Get Full Access of reports @
https://www.databridgemarketresearch.com/reports/north-america-plasma-fractionation-market
MAJOR TOC OF THE REPORT
https://www.databridgemarketresearch.com/toc/?dbmr=north-america-plasma-fractionation-market
Chapter One: Introduction
Chapter Two: Market Segmentation
Chapter Three: Market Overview
Chapter Four: Executive Summary
Chapter Five: Premium Insights
Chapter Six: North America Plasma Fractionation Market
Top Trending Reports@
https://www.databridgemarketresearch.com/reports/europe-plasma-fractionation-market
https://www.databridgemarketresearch.com/reports/asia-pacific-plasma-fractionation-market
https://www.databridgemarketresearch.com/reports/middle-east-and-africa-plasma-fractionation-market
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: Sopan.gedam@databridgemarketresearch.com
English
Spanish (Español)
Arabic
Portuguese (Português)
Deutsch
Turkish (Türk)
Dutch (Nederlands)
Italiano
Romaian (Română)
Português (Brasil)
Greek (Ελληνικά)
Russian (русский)